- Home
- OPT vs HCKT Comparison
OPT vs HCKT Comparison
Compare OPT & HCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPT
- HCKT
- Stock Information
- Founded
- OPT 1984
- HCKT 1991
- Country
- OPT Australia
- HCKT United States
- Employees
- OPT N/A
- HCKT N/A
- Industry
- OPT Biotechnology: Biological Products (No Diagnostic Substances)
- HCKT Professional Services
- Sector
- OPT Health Care
- HCKT Consumer Discretionary
- Exchange
- OPT Nasdaq
- HCKT Nasdaq
- Market Cap
- OPT 767.9M
- HCKT 843.0M
- IPO Year
- OPT 2020
- HCKT 1998
- Fundamental
- Price
- OPT $3.60
- HCKT $31.04
- Analyst Decision
- OPT Strong Buy
- HCKT Strong Buy
- Analyst Count
- OPT 1
- HCKT 3
- Target Price
- OPT $12.00
- HCKT $30.00
- AVG Volume (30 Days)
- OPT 9.2K
- HCKT 90.2K
- Earning Date
- OPT 08-30-2024
- HCKT 02-18-2025
- Dividend Yield
- OPT N/A
- HCKT 1.07%
- EPS Growth
- OPT N/A
- HCKT N/A
- EPS
- OPT N/A
- HCKT 1.22
- Revenue
- OPT $261,859.00
- HCKT $300,739,000.00
- Revenue This Year
- OPT N/A
- HCKT $8.66
- Revenue Next Year
- OPT $46,864.64
- HCKT $5.16
- P/E Ratio
- OPT N/A
- HCKT $25.21
- Revenue Growth
- OPT N/A
- HCKT 4.09
- 52 Week Low
- OPT $1.79
- HCKT $20.23
- 52 Week High
- OPT $5.45
- HCKT $32.83
- Technical
- Relative Strength Index (RSI)
- OPT 52.65
- HCKT 51.61
- Support Level
- OPT $3.15
- HCKT $30.30
- Resistance Level
- OPT $3.39
- HCKT $31.58
- Average True Range (ATR)
- OPT 0.17
- HCKT 0.67
- MACD
- OPT 0.05
- HCKT -0.29
- Stochastic Oscillator
- OPT 72.31
- HCKT 29.25
About OPT Opthea Limited
Opthea Ltd operates in one industry being the medical technology and healthcare. It is focused on developing biological therapeutics for eye diseases. The company is developing a novel biologic therapy, OPT-302, for the treatment of eye diseases. Its products are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors C and D and R3 targets. Opthea's development activities are based on an intellectual property portfolio covering key targets Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. The company geographically operates Australia and United States.
About HCKT Hackett Group Inc (The).
The Hackett Group Inc is an IP-based executive advisory, strategic consulting, and digital transformation firm. It provides Generative Artificial Intelligence ("Gen AI") strategy, operations, finance, human capital management, strategic sourcing, procurement, and information technology. It operates in three segments Oracle Solutions, SAP Solutions, and Global S&BT. It generates the majority of its revenue from the Global S&BT segment in the United States.